Format

Send to

Choose Destination
Arch Gynecol Obstet. 2001 Aug;265(3):119-23.

Lunelle monthly injectable contraceptive. An effective, safe, and convenient new birth control option.

Author information

1
Department of Obstetrics and Gynecology, University of Florida, Jacksonville 32209, USA. andrew.kaunitz@jax.ufl.edu

Abstract

Lunelle, an injectable estrogen/progestin contraceptive, is administered on a monthly basis and is now available as the first monthly injectable in the United States. International and US clinical trials have established its safety and confirmed its contraceptive efficacy. Fertility returns rapidly after discontinuation of injections. Studies have noted a high level of patient satisfaction with Lunelle, suggesting that monthly injectable contraception will become a first-line contraceptive option in the United States.

PMID:
11561738
DOI:
10.1007/s004040100174
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center